Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
Blood-Borne Pathogens
/ isolation & purification
Diagnostic Tests, Routine
/ statistics & numerical data
Health Knowledge, Attitudes, Practice
Health Surveys
Humans
Informed Consent
Mass Screening
/ organization & administration
Patient Acceptance of Health Care
/ statistics & numerical data
Prisoners
Prisons
/ organization & administration
Refusal to Participate
/ statistics & numerical data
Blood-borne virus
Hepatitis B
Hepatitis C
Human immunodeficiency virus
Opt-out
Prison
Testing
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
08 Mar 2019
08 Mar 2019
Historique:
received:
27
02
2018
accepted:
21
02
2019
entrez:
10
3
2019
pubmed:
10
3
2019
medline:
18
5
2019
Statut:
epublish
Résumé
Prisons represent a unique opportunity to diagnose blood-borne viruses. Opt-out testing is receiving increasing interest, as a result of mounting evidence to suggest that the manner in which a test offer is delivered, affects test uptake. Although the effectiveness of opt-out testing within the prison setting has been established, robust explanations are required for the variation in outcomes reported. Rapid-realist review methodology was used to synthesise the literature on prison-based opt-out testing. The review was carried out in three phases. Phase one: An expert panel provided literature relevant to the implementation of opt-out testing within the English prison estate. Unstructured searches were also conducted to identify other social programmes where "opt-out" had been used to increase uptake. Phase two: a systematic search of six peer-review and five grey literature databases was carried out to identify empirical data on opt-out testing within the prison setting. Phase three: Additional non-exhaustive searches were carried out to identify literature that reinforced emergent concepts. The development of programme theory took place with each iteration and was validated in consultation with stakeholders. Programme theory was constructed for two outcomes: the proportion of intake offered a test and the proportion offered that accepted testing. The proportion of intake offered testing was influenced by the timing of the test offer, which was often delayed due to barriers to prisoner access. The decision to accept testing was influenced by concerns about confidentiality, fear of a positive diagnosis, a prisoner's personal interpretation of risk, discomfort with invasive procedures, trust in healthcare, and the fidelity of the opt-out offer. This review identified important implementation considerations that moderate the effectiveness of opt-out testing programmes. It also highlighted a lack of appreciation for the theoretical underpinnings of opt-out programmes and tension around how to implement testing in a manner that adheres to both default theory and informed consent. It is anticipated that results will be used to inform the design and implementation of subsequent versions of these programmes, as well as catalyse further in-depth analysis into their operation within the unique context of prison. CRD42017068342 .
Sections du résumé
BACKGROUND
BACKGROUND
Prisons represent a unique opportunity to diagnose blood-borne viruses. Opt-out testing is receiving increasing interest, as a result of mounting evidence to suggest that the manner in which a test offer is delivered, affects test uptake. Although the effectiveness of opt-out testing within the prison setting has been established, robust explanations are required for the variation in outcomes reported.
METHODS
METHODS
Rapid-realist review methodology was used to synthesise the literature on prison-based opt-out testing. The review was carried out in three phases. Phase one: An expert panel provided literature relevant to the implementation of opt-out testing within the English prison estate. Unstructured searches were also conducted to identify other social programmes where "opt-out" had been used to increase uptake. Phase two: a systematic search of six peer-review and five grey literature databases was carried out to identify empirical data on opt-out testing within the prison setting. Phase three: Additional non-exhaustive searches were carried out to identify literature that reinforced emergent concepts. The development of programme theory took place with each iteration and was validated in consultation with stakeholders.
RESULTS
RESULTS
Programme theory was constructed for two outcomes: the proportion of intake offered a test and the proportion offered that accepted testing. The proportion of intake offered testing was influenced by the timing of the test offer, which was often delayed due to barriers to prisoner access. The decision to accept testing was influenced by concerns about confidentiality, fear of a positive diagnosis, a prisoner's personal interpretation of risk, discomfort with invasive procedures, trust in healthcare, and the fidelity of the opt-out offer.
CONCLUSIONS
CONCLUSIONS
This review identified important implementation considerations that moderate the effectiveness of opt-out testing programmes. It also highlighted a lack of appreciation for the theoretical underpinnings of opt-out programmes and tension around how to implement testing in a manner that adheres to both default theory and informed consent. It is anticipated that results will be used to inform the design and implementation of subsequent versions of these programmes, as well as catalyse further in-depth analysis into their operation within the unique context of prison.
REVIEW REGISTRATION
BACKGROUND
CRD42017068342 .
Identifiants
pubmed: 30849986
doi: 10.1186/s12913-019-3970-z
pii: 10.1186/s12913-019-3970-z
pmc: PMC6408812
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
152Références
AIDS Educ Prev. 2003 Dec;15(6):547-60
pubmed: 14711167
Transplantation. 2004 Dec 27;78(12):1713-6
pubmed: 15614141
Clin Infect Dis. 2005 Jan 15;40(2):319; author reply 319-21
pubmed: 15655733
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:21-34
pubmed: 16053581
N Engl J Med. 2006 Aug 17;355(7):647-9
pubmed: 16914699
BMC Public Health. 2007 Jun 07;7:98
pubmed: 17555573
N Engl J Med. 2007 Sep 27;357(13):1340-4
pubmed: 17898105
J Viral Hepat. 2008 Apr;15(4):250-4
pubmed: 18086182
Addiction. 2008 Oct;103(10):1593-603
pubmed: 18821870
PLoS One. 2009 Nov 25;4(11):e7648
pubmed: 19946370
PLoS One. 2009 Nov 25;4(11):e8056
pubmed: 19946371
Int J STD AIDS. 2010 Feb;21(2):114-9
pubmed: 20089997
MMWR Morb Mortal Wkly Rep. 2010 Jun 25;59(24):742-5
pubmed: 20577155
J Correct Health Care. 2010 Oct;16(4):310-21
pubmed: 20881145
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S49-55
pubmed: 21045600
Implement Sci. 2011 Mar 20;6:24
pubmed: 21418604
BMC Public Health. 2011 Apr 10;11:222
pubmed: 21477347
AIDS Educ Prev. 2011 Jun;23(3 Suppl):96-109
pubmed: 21689040
MMWR Morb Mortal Wkly Rep. 2011 Jun 24;60(24):811-3
pubmed: 21697805
Am J Public Health. 2012 May;102 Suppl 2:S184-6
pubmed: 22401524
Camb Q Healthc Ethics. 2013 Jan;22(1):33-44
pubmed: 23206356
J Adv Nurs. 2013 May;69(5):1005-22
pubmed: 23356726
BMC Med. 2013 Jan 29;11:21
pubmed: 23360677
Hepatology. 2013 Oct;58(4):1215-24
pubmed: 23504650
MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):495-7
pubmed: 23784013
Implement Sci. 2013 Sep 05;8:103
pubmed: 24007206
J Forensic Nurs. 2013 Jul-Sep;9(3):154-61
pubmed: 24158153
Trends Microbiol. 2013 Dec;21(12):625-33
pubmed: 24238778
AIDS. 2014 Jan 14;28(2):281-3
pubmed: 24361685
Sex Transm Dis. 2014 Mar;41(3):161-5
pubmed: 24521720
Health Aff (Millwood). 2014 Jun;33(6):1103
pubmed: 24889961
Eur J Public Health. 2015 Apr;25(2):351-7
pubmed: 25061233
J Public Health Manag Pract. 2015 Nov-Dec;21(6):538-45
pubmed: 25427254
AIDS Care. 2015;27(5):545-54
pubmed: 25506799
Implement Sci. 2015 Apr 16;10:49
pubmed: 25885787
Eur J Public Health. 2015 Dec;25(6):1078-88
pubmed: 26219884
BMC Public Health. 2015 Jul 30;15:725
pubmed: 26223523
AIDS Behav. 2016 Apr;20(4):859-69
pubmed: 26386591
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):e85-8
pubmed: 26536318
Int J Health Sci (Qassim). 2015 Jul;9(3):293-303
pubmed: 26609294
BMJ. 2016 Jan 19;532:h6895
pubmed: 26786744
MMWR Morb Mortal Wkly Rep. 2016 Feb 26;65(7):178-81
pubmed: 26914322
Int J Prison Health. 2016;12(1):17-26
pubmed: 26933989
Implement Sci. 2016 Apr 04;11:47
pubmed: 27044401
J Health Care Poor Underserved. 2016;27(2A):71-100
pubmed: 27133513
Public Health Rep. 2016 May-Jun;131 Suppl 2:98-104
pubmed: 27168668
J Clin Nurs. 2017 Feb;26(3-4):341-355
pubmed: 27434511
AIDS Educ Prev. 2016 Apr;28(2):103-16
pubmed: 27459162
J Clin Nurs. 2017 Jul;26(13-14):1861-1868
pubmed: 27486922
J Public Health (Oxf). 2017 Dec 1;39(4):e290-e301
pubmed: 27679663
J Adv Nurs. 2017 Aug;73(8):1775-1791
pubmed: 27943483
BMC Health Serv Res. 2017 Feb 4;17(1):113
pubmed: 28160771
J Antimicrob Chemother. 2017 Sep 1;72(9):2418-2430
pubmed: 28859445